BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 807755)

  • 1. [Therapeutic effect of lividomycin on infections of the respiratory tract (author's transl)].
    Tsukamura M
    Jpn J Antibiot; 1975 Apr; 28(2):143-8. PubMed ID: 807755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effects of lividomycin on respiratory tract infections, primarily wet cases of bronchiectasis (author's transl)].
    Mashima T; Terada G
    Jpn J Antibiot; 1975 Apr; 28(2):155-65. PubMed ID: 239263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences of lividomycin on respiratory tract infections (author's transl)].
    Kondo H; Miwa T; Suhachiro M; Yokouchi S; Ando Y
    Jpn J Antibiot; 1975 Apr; 28(2):149-54. PubMed ID: 1041282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the therapeutic effects of lividomycin in respiratory infections (author's transl)].
    Aoyagi T; Kawai T; Yamada Y; Gomi J; Ogiwara K
    Jpn J Antibiot; 1975 Apr; 28(2):166-74. PubMed ID: 807756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility of bacteria isolated from the patients with lower respiratory tract infections to antibiotics (1985)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Terai T
    Jpn J Antibiot; 1987 Sep; 40(9):1669-97. PubMed ID: 3121887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
    Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibility of bacteria isolated from patients with lower respiratory tract infections to antibiotics (1987)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Kondou T; Saitou A; Matsumiya H; Ueda K; Terai T
    Jpn J Antibiot; 1990 Jan; 43(1):147-80. PubMed ID: 2112206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacterial agents responsible for urinary tract infections. III. A clinico-statistical contribution].
    Roscioni C; Pennelli GM; Monaco G; Roscioni MC
    Clin Ter; 1988 Aug; 126(3):207-15. PubMed ID: 2974387
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with cefadroxil in upper and lower respiratory tract infections.
    Mercado FF; Santella PJ; Fernandez CA
    J Int Med Res; 1978; 6(4):271-9. PubMed ID: 357229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of cefminox in respiratory tract infections].
    Odagiri S; Ikeda H; Suzuki K; Murohashi K; Kaneko T
    Jpn J Antibiot; 1985 May; 38(5):1165-77. PubMed ID: 3930783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical study on panipenem/betamipron in chronic respiratory tract infections].
    Odagiri S; Matsumura M; Suzuki K; Murohashi K; Takahashi K; Ashikari Y; Yoshioka T; Matsumoto F; Imai T; Takeguchi K
    Jpn J Antibiot; 1992 Feb; 45(2):160-71. PubMed ID: 1613969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of bacteria isolated from patients with lower respiratory tract infections to antibiotics (1986)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Kondou T; Saitou A; Matsumiya H; Ueda K; Terai T
    Jpn J Antibiot; 1989 Nov; 42(11):2324-53. PubMed ID: 2695657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of a new oral cephalosporin preparation, cephradine dry syrup, in pediatrics (author's transl)].
    Fujii R; Yoshioka H; Nakamura T; Nakazawa S; Hori M
    Jpn J Antibiot; 1975 Apr; 28(2):125-31. PubMed ID: 239262
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
    Lanni N; Scaglione B
    Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.